Trends in office-based treatment of adults with stimulants in the United States
- PMID: 23419225
- DOI: 10.4088/JCP.12m07975
Trends in office-based treatment of adults with stimulants in the United States
Abstract
Objective: The authors investigated trends and patterns in stimulant treatment of adults visiting office-based medical practices in the United States.
Method: A time series analysis of data from the 1994 to 2009 National Ambulatory Medical Care Surveys (no. of visits = 372,702) was performed, focusing on adult (aged ≥ 18 years) visits in which stimulant medications (amphetamine salts, methylphenidate, or pemoline) were prescribed. The authors computed trends in the percentage of visits in which a stimulant was prescribed stratified by background and clinical patient characteristics. Results are reported as odds ratios (ORs) over the 1994 to 2009 period. The authors also compare visits to psychiatrists and nonpsychiatrist physicians that yielded a stimulant prescription to an adult.
Results: The percentage of visits in which stimulants were prescribed increased from 0.11% (1994-1997) to 0.70% (2006-2009) (OR = 13.72, 95% confidence interval [CI], 9.40-20.03). Among adults aged 18 to 29 years, the corresponding increase in stimulant visits was from 0.17% to 1.83% (OR = 30.14, 95% CI, 15.84-57.36). Stimulant prescriptions increased significantly more rapidly among visits without a clinical ADHD diagnosis (OR = 11.86, 95% CI, 7.49-18.80) than among visits with such a diagnosis (OR = 5.45, 95% CI, 2.96-10.04) (interaction P = .04) and among visits to nonpsychiatrist physicians (OR = 21.54, 95% CI, 12.84-36.12) than psychiatrists (OR = 10.64, 95% CI, 6.72-16.86) (interaction P = .03). By 2006-2009, nonpsychiatrist physicians provided most (57.7%) of the stimulant prescriptions linked to adult office-based visits. As compared with psychiatrists, nonpsychiatrist physicians diagnosed ADHD in a significantly smaller proportion of their adult visits in which stimulants were prescribed (62.5% vs 34.4%, P < .0001).
Conclusions: Between 1994 and 2009, there was a substantial increase in stimulant prescriptions during adult outpatient visits, especially during visits of younger adults. The increase in stimulant treatment occurred significantly more rapidly in the practices of nonpsychiatrist physicians than in those of psychiatrists.
© Copyright 2013 Physicians Postgraduate Press, Inc.
Similar articles
-
National trends in psychotropic medication polypharmacy in office-based psychiatry.Arch Gen Psychiatry. 2010 Jan;67(1):26-36. doi: 10.1001/archgenpsychiatry.2009.175. Arch Gen Psychiatry. 2010. PMID: 20048220
-
National trends in psychotherapy by office-based psychiatrists.Arch Gen Psychiatry. 2008 Aug;65(8):962-70. doi: 10.1001/archpsyc.65.8.962. Arch Gen Psychiatry. 2008. PMID: 18678801
-
National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.Arch Gen Psychiatry. 2006 Jun;63(6):679-85. doi: 10.1001/archpsyc.63.6.679. Arch Gen Psychiatry. 2006. PMID: 16754841
-
Recent Trends in Stimulant Usage.J Atten Disord. 2016 Jun;20(6):471-7. doi: 10.1177/1087054715605915. Epub 2015 Oct 20. J Atten Disord. 2016. PMID: 26486603 Review.
-
ADHD and the rise in stimulant use among children.Harv Rev Psychiatry. 2008;16(3):151-66. doi: 10.1080/10673220802167782. Harv Rev Psychiatry. 2008. PMID: 18569037 Review.
Cited by
-
Examining the Myth of Prescribed Stimulant Misuse among Individuals with Attention-Deficit/Hyperactivity Disorder: A Systematic Review.Pharmaceuticals (Basel). 2024 Aug 16;17(8):1076. doi: 10.3390/ph17081076. Pharmaceuticals (Basel). 2024. PMID: 39204181 Free PMC article. Review.
-
Attention-deficit hyperactivity disorder diagnoses and prescriptions in UK primary care, 2000-2018: population-based cohort study.BJPsych Open. 2023 Jul 17;9(4):e121. doi: 10.1192/bjo.2023.512. BJPsych Open. 2023. PMID: 37455585 Free PMC article.
-
Trends in Stimulant Prescription Fills Among Commercially Insured Children and Adults - United States, 2016-2021.MMWR Morb Mortal Wkly Rep. 2023 Mar 31;72(13):327-332. doi: 10.15585/mmwr.mm7213a1. MMWR Morb Mortal Wkly Rep. 2023. PMID: 36995976 Free PMC article.
-
Neuroprotection in late life attention-deficit/hyperactivity disorder: A review of pharmacotherapy and phenotype across the lifespan.Front Hum Neurosci. 2022 Sep 26;16:938501. doi: 10.3389/fnhum.2022.938501. eCollection 2022. Front Hum Neurosci. 2022. PMID: 36226261 Free PMC article. Review.
-
Treatment with stimulants and the risk of COVID-19 complications in adults with ADHD.Brain Res Bull. 2022 Sep;187:155-161. doi: 10.1016/j.brainresbull.2022.07.005. Epub 2022 Jul 14. Brain Res Bull. 2022. PMID: 35839903 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
